Sooma Oy is a Finnish medical device company developing non-invasive brain stimulation devices for treatment of neurological and psychiatric disorders. Since its establishment in 2013, Sooma has been working closely with leading experts in psychiatry and clinical neurophysiology to provide better care for all of us.
Sooma tDCS, a low threshold therapy solution for major depressive disorder, was launched at the end of 2014. The treatment is safe, effective, well tolerated and suitable for most people.
Sooma Ltd is committed to provide neurological therapy devices and services that meet customer and regulatory requirements by maintaining an effective quality management system. We at Sooma are maintaining and continuously improving our quality system by managing all product related risks and achieving objectives related to:
Quality system planning and improvement
Supplier quality assurance
Personnel training and competence
Regulatory compliance and internal/external audits
Process effectiveness and efficiency